EMEA-001142-PIP01-11-M04
Key facts
| Invented name |
Zerbaxa
|
| Active substance |
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0436/2020
|
| PIP number |
EMEA-001142-PIP01-11-M04
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
E-mail: pip.information@merck.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001142-PIP01-11-M04
|
| Compliance opinion date |
25/06/2021
|
| Compliance outcome |
positive
|